Skip to main content

ABNX · ABIONYX PHARMA · Documents

1.6040 EUR 15-min delayed · Oct 5, 15:35 UTC
Market Cap
77.53M EUR
Shares
43.51M

ABIONYX PHARMA's financial reports and regulated publications, as filed with the market regulator, most recent first.

Type Filing Date Period Open
Showing 1–5 of 5 filings

Official financial reports

Official annual, half-year and quarterly publication attachments from DILA / AMF. These are source links, not extracted financial figures. Publication dates are not reporting periods. One publication can have multiple attachments. Source revisions remain separate; do not treat every entry as a current report. Only captured publication months are covered, and gaps may exist. Freshness covers every captured month; CheckedAt is the oldest month check.

Financial report publications from DILA / AMF — info-financière
Published (UTC)ReportTypeSource revision
2024-11-14 Information financière trimestrielle / Information financière du troisième trimestre Français · 160150_20241114 Quarterly financial information NEW
2024-11-14 Quarterly financial reporting / Third quarter financial report Anglais · 160151_20241114 Quarterly financial information NEW
2020-10-22 Information financière trimestrielle / Information financière du troisième trimestre Français · 129318_20201022 Quarterly financial information NEW
2020-10-22 Quarterly financial reporting / Third quarter financial report Anglais · 129319_20201022 Quarterly financial information NEW
2019-10-24 Information financière trimestrielle / Information financière du troisième trimestre Français · 121472_20191024 Quarterly financial information NEW
2019-10-24 Quarterly financial reporting / Third quarter financial report Anglais · 121473_20191024 Quarterly financial information NEW

238 publication months captured between 2007-01 and 2026-10; gaps may exist. Oldest month check 2026-09-21 02:08 UTC.

Showing 1–6 of 6 publications